PortfoliosLab logoPortfoliosLab logo
UDOW vs. CURE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

UDOW vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares UltraPro Dow30 (UDOW) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UDOW achieves a 22.92% return, which is significantly higher than CURE's 6.23% return. Over the past 10 years, UDOW has outperformed CURE with an annualized return of 23.01%, while CURE has yielded a comparatively lower 13.82% annualized return.


UDOW

1D
-0.72%
1M
2.22%
6M
13.51%
YTD
22.92%
1Y
51.04%
3Y*
34.50%
5Y*
15.05%
10Y*
23.01%

CURE

1D
6.20%
1M
17.48%
6M
2.51%
YTD
6.23%
1Y
54.41%
3Y*
8.53%
5Y*
2.31%
10Y*
13.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

UDOW vs. CURE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UDOW
ProShares UltraPro Dow30
22.92%24.46%28.47%32.72%-32.39%65.67%-17.15%75.24%-23.86%99.07%
CURE
Direxion Daily Healthcare Bull 3x Shares
6.23%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%

Correlation

The correlation between UDOW and CURE is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.46

Correlation (3Y)
Calculated over the trailing 3-year period

0.61

Correlation (5Y)
Calculated over the trailing 5-year period

0.67

Correlation (10Y)
Calculated over the trailing 10-year period

0.68

Correlation (All Time)
Calculated using the full available price history since Jun 15, 2011

0.71

Over the past year, the correlation between UDOW and CURE has dropped to 0.46 - well below their long-term average of 0.71, suggesting their price drivers have been diverging.

UDOW vs. CURE - Sectors Allocation Comparison


Sectors
UDOW
CURE

Financial Services

27.3%

-

Technology

19.1%

-

Industrials

18.1%

-

Healthcare

12.8%
100.0%

Consumer Cyclical

11.0%

-

Consumer Defensive

4.1%

-

Basic Materials

3.7%

-

Energy

2.2%

-

Communication Services

1.8%

-

Real Estate

-

-

Utilities

-

-

Financial Services

UDOW
27.3%
CURE

-

Technology

UDOW
19.1%
CURE

-

Industrials

UDOW
18.1%
CURE

-

Healthcare

UDOW
12.8%
CURE
100.0%

Consumer Cyclical

UDOW
11.0%
CURE

-

Consumer Defensive

UDOW
4.1%
CURE

-

Basic Materials

UDOW
3.7%
CURE

-

Energy

UDOW
2.2%
CURE

-

Communication Services

UDOW
1.8%
CURE

-

Real Estate

UDOW

-

CURE

-

Utilities

UDOW

-

CURE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UDOW vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UDOW
UDOW Risk / Return Rank: 4747
Overall Rank
UDOW Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
UDOW Sortino Ratio Rank: 5050
Sortino Ratio Rank
UDOW Omega Ratio Rank: 4646
Omega Ratio Rank
UDOW Calmar Ratio Rank: 4444
Calmar Ratio Rank
UDOW Martin Ratio Rank: 4848
Martin Ratio Rank

CURE
CURE Risk / Return Rank: 4040
Overall Rank
CURE Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 4545
Sortino Ratio Rank
CURE Omega Ratio Rank: 3838
Omega Ratio Rank
CURE Calmar Ratio Rank: 4242
Calmar Ratio Rank
CURE Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UDOW vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares UltraPro Dow30 (UDOW) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


UDOWCUREDifference
Sharpe ratioReturn per unit of total volatility

+0.23

Sortino ratioReturn per unit of downside risk

+0.11

Omega ratioGain probability vs. loss probability

1.24

1.21

+0.03

Calmar ratioReturn relative to maximum drawdown

1.83

1.76

+0.07

Martin ratioReturn relative to average drawdown

6.48

3.91

+2.56

UDOW vs. CURE - Sharpe Ratio Comparison

The current UDOW Sharpe Ratio is 1.40, which is comparable to the CURE Sharpe Ratio of 1.17. The chart below compares the historical Sharpe Ratios of UDOW and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

UDOW vs. CURE - Drawdown Comparison

The maximum UDOW drawdown since its inception was -80.29%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for UDOW and CURE.


Loading charts...

Drawdown Indicators


UDOWCUREDifference

Max Drawdown

Largest peak-to-trough decline

-80.29%

-69.19%

-11.10%

Max Drawdown (1Y)

Largest decline over 1 year

-28.07%

-31.10%

+3.03%

Max Drawdown (3Y)

Largest decline over 3 years

-44.83%

-51.93%

+7.10%

Max Drawdown (5Y)

Largest decline over 5 years

-55.79%

-52.23%

-3.56%

Max Drawdown (10Y)

Largest decline over 10 years

-80.29%

-69.19%

-11.10%

Current Drawdown

Current decline from peak

-3.29%

-15.68%

+12.39%

Average Drawdown

Average peak-to-trough decline

-14.30%

-18.17%

+3.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.90%

13.95%

-6.05%

Volatility

UDOW vs. CURE - Volatility Comparison

The current volatility for ProShares UltraPro Dow30 (UDOW) is 6.90%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 18.67%. This indicates that UDOW experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UDOWCUREDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.90%

18.67%

-11.77%

Volatility (6M)

Calculated over the trailing 6-month period

28.66%

34.60%

-5.94%

Volatility (1Y)

Calculated over the trailing 1-year period

36.53%

46.78%

-10.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

44.29%

44.55%

-0.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

51.67%

49.74%

+1.93%

UDOW vs. CURE - Expense Ratio Comparison

UDOW has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.


Dividends

UDOW vs. CURE - Dividend Comparison

UDOW's dividend yield for the trailing twelve months is around 1.09%, more than CURE's 1.07% yield.


PositionTTM20252024202320222021202020192018201720162015
CURE
Direxion Daily Healthcare Bull 3x Shares
1.07%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%
UDOW
ProShares UltraPro Dow30
1.09%1.38%0.95%0.95%0.83%0.26%0.19%0.61%0.73%0.13%0.26%0.21%

Frequently Asked Questions


UDOW and CURE have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CURE has higher volatility (18.67%) compared to UDOW (6.90%). In terms of maximum drawdown, UDOW dropped -80.29% vs CURE's -69.19%.

On 10-year performance, UDOW leads with 23.01% vs 13.82% for CURE. On fees, UDOW is cheaper at 0.95% per year. On volatility, UDOW has been the lower-risk option at 6.90%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, UDOW has performed better with a 23.01% return vs 13.82%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

UDOW is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.

UDOW has the higher dividend yield at 1.09%, compared with 1.07% for CURE.

UDOW tracks Dow Jones Industrial Average (300%), while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for UDOW and 1.08% for CURE.

UDOW currently has the higher Sharpe Ratio (1.40 vs 1.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UDOW and CURE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer